![]() |
市场调查报告书
商品编码
1380422
2023-2030 年全球医疗保健市场电脑视觉Global Computer Vision in Healthcare Market 2023-2030 |
预计在预测期内(2023-2030 年),医疗保健市场的全球电脑视觉将以 43.2% 的CAGR成长。电脑视觉在医疗保健领域有广泛的应用,例如诊断影像、病理学、外科手术、病患监护、药物发现和远距医疗等。电脑视觉的使用减少了出错的机会,提高了疾病诊断、手术干预和远端患者评估的速度和准确性,最终改善了医疗保健结果。除此之外,对具有成本效益的解决方案不断增长的需求以及医疗错误的减少都推动了其采用。这些组合要素在加强病患照护和简化医疗保健系统效率方面发挥着至关重要的作用。
全球医疗保健市场电脑视觉根据类型、应用程式和最终用户进行细分。根据类型,市场分为软体、硬体和服务。根据应用,市场细分为医学影像和诊断、手术、患者监护以及药物发现、患者教育和康復等其他应用。根据最终用户,市场细分为医疗保健提供者、诊断中心、学术研究机构以及製药公司和医疗器材公司等其他机构。在最终用户中,製药业对基于电脑视觉的解决方案的需求正在不断增长。在药品製造中,电脑视觉可用于多种应用,例如产品品质检查、包装检测、压印药品标籤分类和清洁检查。获得严格的 FDA 法规来维持和提高产品品质、製药行业的持续成长以及监管机构对将 AI/ML 等新技术纳入製造过程的日益支持,正在推动製药行业对电脑视觉技术的需求。例如,根据美国 FDA 的器械品质系统规定,製造商必须建立并遵循品质体系,以协助确保其产品始终符合适用的要求和规范。考虑到不断增长的需求和用例,科技公司也将重点放在与製药业相关的产品上。
其中,医疗器材细分市场预计将占据显着的市场份额。基于电脑视觉的医疗设备在医疗保健领域有着广泛的应用,可显着提高病患照护和诊断准确性。它们用于诊断成像、病理分析和手术精度,确保更好、更精确的医疗评估和治疗。除此之外,这些设备还用于远距患者监护、远距医疗咨询、牙科影像和眼科评估,所有这些都共同提高了医疗保健服务的效率和有效性。
医疗保健市场的全球电脑视觉根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于医疗保健的可及性更好以及终端用户行业市场领导者的大量存在等因素,北美在市场中占有相当大的份额。此外,对人工智慧/机器学习等先进技术的投资不断增加,技术进步也不断增加。例如,2023 年 2 月,Modular Devices 和 O2 Investment Partners 的投资组合公司向 Interim Diagnostic Imaging 投资了一笔金额未揭露的资金。透过此次合作,该公司将专注于研发和产品组合扩展。
根据国际货币基金组织的数据,亚太地区拥有全球 60% 的人口。由于人口占全球人口的大多数且正在显着增长,地方政府正致力于透过引入更好的政策、投资和采用人工智慧/机器学习等先进技术来改善医疗保健系统,以提高医疗保健效率。此外,主要区域经济体也纷纷推出政策来促进医疗器材、医院等终端用户产业的发展。例如,2022 年 7 月,印度政府提出了新的《2022 年药品、医疗器材和化妆品法案》草案,以确保并提供彻底的法律保护,以确保在印度销售的医疗用品可靠、高效、符合要求。要求的标准。这些措施也帮助 SigTuple 和 Qure.ai 等区域公司在国际市场上保持竞争力。
服务全球医疗保健电脑视觉的主要公司包括: Enlitic, Inc.、Caption Health, Inc.、推想医疗科技有限公司和 Medtronic, plc 等。市场参与者透过各种策略(包括併购、合作伙伴关係和融资)来维持市场竞争力,为市场成长做出了巨大贡献。例如,2022 年 1 月,DarioHealth Corp. 收购了 Physimax Technologies Ltd。Physimax Technologies 是一家用于肌肉骨骼 (MSK) 功能筛检和损伤预测风险评估的电脑视觉技术提供者。该技术目前已被多个组织投入商业使用,包括 NBA 和 NFL 球队、美国军方以及专门从事骨科护理的医疗机构。
Title: Global Computer Vision in Healthcare Market Size, Share & Trends Analysis Report by Type (Hardware, Software, and Services), by Application (Medical Imaging & Diagnostics, Surgeries, Patient Monitoring, and Others), and by End User (Healthcare Providers, Diagnostic Centers, Academic Research Institutes, and Others)Forecast Period (2023-2030).
The global computer vision in the healthcare market is anticipated to grow at a CAGR of 43.2% during the Forecast Period (2023-2030). Computer vision has a wide range of applications in healthcare such as diagnostic imaging, pathology, surgical procedures, patient monitoring, drug discovery, and telemedicine, among others. Usage of computer vision reduces the chances of errors and improves speed, and accuracy of disease diagnosis, surgical interventions, and remote patient assessments, ultimately leading to enhanced healthcare outcomes. Apart from this, the growing demand for cost-effective solutions, and decreased medical errors, are all driving its adoption. These combined elements play a crucial role in enhancing patient care and streamlining the efficiency of the healthcare system.
The global computer vision in healthcare market is segmented based on the type, application, and end user. Based on type, the market is sub-segmented into software, hardware, and services. Based on application, the market is sub-segmented into medical imaging & and diagnostics, surgeries, patient monitoring, and other applications such as drug discovery, patient education, and rehabilitation. Based on end users, the market is sub-segmented into healthcare providers, diagnostic centers, academic research institutes, and others such as pharmaceutical companies, and medical device companies. Among the end users, significant demand for computer vision-based solutions is growing in the pharmaceutical industry. In pharmaceutical manufacturing, computer vision can be used for multiple applications such as quality inspection of a product, packaging detection, classification of imprinted pharmaceutical labels, and cleaning inspections. Getting stringent FDA regulations to maintain and improve product quality, the continuous growth of the pharmaceutical industry, and growing support from regulators for the inclusion of new technologies such as AI/ML in the manufacturing processes are driving demand for computer vision technology in the pharmaceutical industry. For instance, according to the USFDA quality system regulation for devices, Manufacturers must establish and follow quality systems to help ensure that their products consistently meet applicable requirements and specifications. Considering growing demand and use cases, technology companies are also focusing on products related to the pharmaceutical industry.
Among the types, the medical devices sub-segment is anticipated to hold a prominent share of the market. Computer vision-based medical devices have a wide range of applications across healthcare, significantly enhancing patient care and diagnostic accuracy. They are used in diagnostic imaging, pathology analysis, and surgical precision, ensuring better and more precise medical assessments & and treatments. Apart from this, these devices are used for remote patient monitoring, telemedicine consultations, dental imaging, and ophthalmology assessments, all of which collectively contribute to the efficiency and effectiveness of healthcare services.
The global computer vision in the healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, North America holds a considerable share in the market due to factors such as better accessibility of healthcare, and the significant presence of market leaders in end-user industries. Furthermore, the growing investments in advanced technologies such as AI/ML, and technological advancements. For instance, in February 2023 Modular Devices and the portfolio company of O2 Investment Partners invested an undisclosed amount in Interim Diagnostic Imaging. With this partnership, the company will focus on research and development, and product portfolio expansion.
Asia-Pacific region holds 60% of the global population, according to the International Monetary Fund. With a majority share of the global population, which is growing significantly, the regional governments are focusing on improving healthcare systems by introducing better policies, investments, and the inclusion of advanced technologies such as AI/ML to improve healthcare efficiency. Additionally, the major regional economies are also introducing policies to promote end-user industries such as medical devices, and hospitals industry. For instance, In July 2022, the government of India tabled a draft for the new Drugs, Medical Devices and Cosmetics Bill 2022, to assure and offer thorough legal protections to ensure that the medical items sold in India are reliable, efficient, and up to required standards. These initiatives are also helping regional companies such as SigTuple, and Qure.ai to stay competitive in the international market.
The major companies serving the global computer vision in healthcare include: Enlitic, Inc., Caption Health, Inc., Infervision Medical Technology Co., Ltd., and Medtronic, plc among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, and funding to stay competitive in the market. For instance, in January 2022, DarioHealth Corp. acquired Physimax Technologies Ltd. Physimax Technologies is a provider of computer vision technology utilized for Musculoskeletal (MSK) functional screening and predictive risk assessment of injuries. This technology is currently in commercial use by various organizations, including NBA and NFL teams, the US military, and healthcare facilities specializing in orthopedic care.